Skip to main content

Shuttle Pharmaceuticals Holdings, Inc.

SHPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001757499

In the last 90 days, Shuttle Pharmaceuticals Holdings, Inc. insiders filed 2 open-market purchases and 3 sales; 5 institutions reported holding it in 13F filings for Q2 2026, worth $338.2K in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Shuttle Pharmaceuticals Holdings, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of SHPH: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders46+2
Shares29.8K356.7K+326.9K (+1,097.0%)
Value$39.2K$306.1K+$266.9K (+680.3%)

New holders (3)

Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to SHPH in Q4 2024
InstitutionSharesValue% of portfolio
Armistice Capital, LLC306,057$262.9K0.01%
UBS Group AG32,787$28.2K0.00%
Geode Capital Management, LLC10,867$9.06K0.00%

Sold out (1)

Institutions that held Shuttle Pharmaceuticals Holdings, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of SHPH in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
HRT Financial LP25,866$34.0K